| COVID-19 and liver dysfunction: current insights and emergent therapeutic strategies G Feng, KI Zheng, QQ Yan, RS Rios, G Targher, CD Byrne, S Van Poucke, ... Journal of clinical and translational hepatology 8 (1), 18, 2020 | 516 | 2020 |
| Obesity is a risk factor for greater COVID-19 severity. F Gao, KI Zheng, XB Wang, QF Sun, KH Pan, TY Wang, YP Chen, ... | 499 | 2020 |
| Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease KI Zheng, F Gao, XB Wang, QF Sun, KH Pan, TY Wang, HL Ma, YP Chen, ... Metabolism-clinical and Experimental 108, 2020 | 423 | 2020 |
| Plasma CRP level is positively associated with the severity of COVID-19 W Chen, KI Zheng, S Liu, Z Yan, C Xu, Z Qiao Annals of clinical microbiology and antimicrobials 19, 1-7, 2020 | 376 | 2020 |
| MAFLD and risk of CKD DQ Sun, Y Jin, TY Wang, KI Zheng, RS Rios, HY Zhang, G Targher, ... Metabolism 115, 154433, 2021 | 232 | 2021 |
| Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores G Targher, A Mantovani, CD Byrne, XB Wang, HD Yan, QF Sun, KH Pan, ... Gut 69 (8), 1545-1547, 2020 | 212 | 2020 |
| Extrapulmonary complications of COVID‐19: A multisystem disease? KI Zheng, G Feng, WY Liu, G Targher, CD Byrne, MH Zheng Journal of medical virology 93 (1), 323-335, 2021 | 198 | 2021 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 180 | 2022 |
| Patients with diabetes are at higher risk for severe illness from COVID-19 G Targher, A Mantovani, XB Wang, HD Yan, QF Sun, KH Pan, CD Byrne, ... Diabetes & metabolism 46 (4), 335, 2020 | 180 | 2020 |
| Younger patients with MAFLD are at increased risk of severe COVID-19 illness: a multicenter preliminary analysis YJ Zhou, KI Zheng, XB Wang, HD Yan, QF Sun, KH Pan, TY Wang, HL Ma, ... Journal of hepatology 73 (3), 719-721, 2020 | 146 | 2020 |
| Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients F Gao, KI Zheng, XB Wang, HD Yan, QF Sun, KH Pan, TY Wang, YP Chen, ... Journal of gastroenterology and hepatology 36 (1), 204-207, 2021 | 127 | 2021 |
| From NAFLD to MAFLD: a" redefining" moment for fatty liver disease KI Zheng, JG Fan, JP Shi, VWS Wong, M Eslam, J George, MH Zheng Chinese medical journal 133 (19), 2271-2273, 2020 | 111 | 2020 |
| Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry C Stephens, M Robles-Diaz, I Medina-Caliz, M Garcia-Cortes, ... Journal of hepatology 75 (1), 86-97, 2021 | 107 | 2021 |
| Metabolic‐associated fatty liver disease is associated with severity of COVID‐19 YJ Zhou, KI Zheng, XB Wang, QF Sun, KH Pan, TY Wang, HL Ma, ... Liver International 40 (9), 2160-2163, 2020 | 103 | 2020 |
| Fatal outcome in a liver transplant recipient with COVID‐19 JF Huang, KI Zheng, J George, HN Gao, RN Wei, HD Yan, MH Zheng American Journal of Transplantation 20 (7), 1907-1910, 2020 | 101 | 2020 |
| Global epidemiology of lean non‐alcoholic fatty liver disease: a systematic review and meta‐analysis FB Lu, KI Zheng, RS Rios, G Targher, CD Byrne, MH Zheng Journal of gastroenterology and hepatology 35 (12), 2041-2050, 2020 | 96 | 2020 |
| COVID-19 in a patient with chronic lymphocytic leukaemia XH Jin, KI Zheng, KH Pan, YP Xie, MH Zheng The Lancet. Haematology 7 (4), e351, 2020 | 90 | 2020 |
| PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels DQ Sun, KI Zheng, G Xu, HL Ma, HY Zhang, XY Pan, PW Zhu, XD Wang, ... Liver International 40 (1), 107-119, 2020 | 81 | 2020 |
| Clinical utility of the MAFLD definition KI Zheng, DQ Sun, Y Jin, PW Zhu, MH Zheng Journal of hepatology 74 (4), 989-991, 2021 | 61 | 2021 |
| A case series of recurrent viral RNA positivity in recovered COVID-19 Chinese patients KI Zheng, XB Wang, XH Jin, WY Liu, F Gao, YP Chen, MH Zheng Journal of General Internal Medicine 35, 2205-2206, 2020 | 56 | 2020 |
Giovanni TargherFull Professor of Endocrinology and Diabetology, University of Verona在 univr.it 的电子邮件经过验证
